By the time of renal transplantation, end-stage renal disease patients have a huge burden of
cardiovascular disease (CVD) and are heavily saturated with atherosclerotic risk factors …

Renal transplant recipients have increased mortality rates when compared with the general
population. The new immunosuppressive drugs have improved short-term patient survival …

Many complications after renal transplantation can be prevented if they are detected early.
Guidelines have been developed for the prevention of diseases in the general population …

Successful kidney transplantation offers patients with end-stage renal disease the greatest
likelihood of survival. However, cardiovascular disease poses a major threat to both graft …

Peripheral arterial occlusive disease (PAOD) accounts for significant morbidity and mortality
among end-stage renal disease (ESRD) patients but has not been as extensively studied as …

The incidence of cardiovascular disease (CVD) is very high in patients with chronic kidney
(CKD) disease and in kidney transplant recipients. Indeed, available evidence for these …

Background. Cardiovascular disease, the most common cause of death with a functioning
graft among kidney transplant recipients, can be exacerbated by immunosuppressive drugs …

Background Antiplatelet agents are widely used to prevent cardiovascular events. The risks
and benefits of antiplatelet treatment may be different in people with chronic kidney disease …

According to recent data, arterial stiffness is a major independent risk factor for
cardiovascular morbidity and mortality in both the general and renal populations. Because of …

Peripheral vascular disease (PVD) is common among patients undergoing hemodialysis,
but little is known regarding the risk factors for PVD in this population. Data from waves 1, 3 …